تقرير تحليل حجم سوق التغذية المعوية في جمهورية التشيك وتوقعاته (2021 - 2031)، والحصة العالمية والإقليمية، والاتجاه، وفرص النمو: حسب نوع المنتج (أنفي معدي، أنفي معوي، شرب، وغيرها)

1.   Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.   Executive Summary

2.1       Key Insights

3.   Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1      Hypothesis formulation:

3.2.2      Macro-economic factor analysis:

3.2.3      Developing base number:

3.2.4      Data Triangulation:

3.2.5      Country level data:

4.   Czech Republic Enteral Nutrition Market Landscape

4.1       Overview

4.2       PEST Analysis

5.   Czech Republic Enteral Nutrition Market – Key Market Dynamics

5.1       Czech Republic Enteral Nutrition Market – Key Market Dynamics

5.2       Market Drivers

5.2.1      Increasing Prevalence of Chronic Diseases

5.2.2      Rising Aging Population

5.3       Market Restraints

5.3.1      High Cost of Enteral Nutrition

5.4       Market Opportunities

5.4.1      Growth of Home Enteral Nutrition

5.5       Future Trends

5.5.1      Personalized Enteral Nutrition Therapy

5.6       Impact of Drivers and Restraints:

6.   Czech Republic Enteral Nutrition Market Analysis

6.1       Czech Republic Enteral Nutrition Market Revenue (US$ Million), 2021–2031

6.2       Czech Republic Enteral Nutrition Market Forecast and Analysis

6.3       Czech Republic Enteral and Parenteral Nutrition Market Value (%)

7.   Czech Republic Enteral Nutrition Market Analysis – by Product Type

7.1       Nasogastric

7.1.1      Overview

7.1.2      Nasogastric: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

7.1.3      Standard

7.1.3.1  Overview

7.1.3.2  Standard: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

7.1.4      Disease Specific

7.1.4.1  Overview

7.1.4.2  Disease Specific: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

7.2       Nasoenteral

7.2.1      Overview

7.2.2      Nasoenteral: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

7.3       Sipping

7.3.1      Overview

7.3.2      Sipping: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

7.4       Others

7.4.1      Overview

7.4.2      Others: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

8.   Czech Republic Enteral Nutrition Market – Country Analysis

8.1       Europe

8.1.1      Czech Republic Enteral Nutrition Market

8.1.1.1  Czech Republic Enteral Nutrition Market Revenue and Forecast and Analysis – by Country

8.1.1.2  Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

8.1.1.2.1   Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Product Type

8.1.1.2.2   Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Nasogastric Type

8.1.1.2.3   Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By Calories

8.1.1.2.4   Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Isocaloric

8.1.1.2.5   Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Hypercaloric

8.1.1.2.6   Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By Type

8.1.1.2.7   Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By End user

9.   Company Profiles

9.1       Nestle SA

9.1.1      Key Facts

9.1.2      Business Description

9.1.3      Products and Services

9.1.4      Financial Overview

9.1.5      SWOT Analysis

9.1.6      Key Developments

9.2       Danone SA

9.2.1      Key Facts

9.2.2      Business Description

9.2.3      Products and Services

9.2.4      Financial Overview

9.2.5      SWOT Analysis

9.2.6      Key Developments

9.3       Abbott Laboratories

9.3.1      Key Facts

9.3.2      Business Description

9.3.3      Products and Services

9.3.4      Financial Overview

9.3.5      SWOT Analysis

9.3.6      Key Developments

9.4       Royal FrieslandCampina NV

9.4.1      Key Facts

9.4.2      Business Description

9.4.3      Products and Services

9.4.4      Financial Overview

9.4.5      SWOT Analysis

9.4.6      Key Developments

9.5       Fresenius SE & Co KGaA

9.5.1      Key Facts

9.5.2      Business Description

9.5.3      Products and Services

9.5.4      Financial Overview

9.5.5      SWOT Analysis

9.5.6      Key Developments

9.6       B Braun SE

9.6.1      Key Facts

9.6.2      Business Description

9.6.3      Products and Services

9.6.4      Financial Overview

9.6.5      SWOT Analysis

9.6.6      Key Developments

9.7       Reckitt Benckiser Group Plc

9.7.1      Key Facts

9.7.2      Business Description

9.7.3      Products and Services

9.7.4      Financial Overview

9.7.5      SWOT Analysis

9.7.6      Key Developments

9.8       Kate Farms Inc

9.8.1      Key Facts

9.8.2      Business Description

9.8.3      Products and Services

9.8.4      Financial Overview

9.8.5      SWOT Analysis

9.8.6      Key Developments

9.9       Dr Schar AG

9.9.1      Key Facts

9.9.2      Business Description

9.9.3      Products and Services

9.9.4      Financial Overview

9.9.5      SWOT Analysis

9.9.6      Key Developments

9.10     Fonterra Co-Operative Group Ltd

9.10.1    Key Facts

9.10.2    Business Description

9.10.3    Products and Services

9.10.4    Financial Overview

9.10.5    SWOT Analysis

9.10.6    Key Developments

9.11     Perrigo Co Plc

9.11.1    Key Facts

9.11.2    Business Description

9.11.3    Products and Services

9.11.4    Financial Overview

9.11.5    SWOT Analysis

9.11.6    Key Developments

9.12     Arla Foods amba

9.12.1    Key Facts

9.12.2    Business Description

9.12.3    Products and Services

9.12.4    Financial Overview

9.12.5    SWOT Analysis

9.12.6    Key Developments

9.13     Charing Cross Scientific AS

9.13.1    Key Facts

9.13.2    Business Description

9.13.3    Products and Services

9.13.4    Financial Overview

9.13.5    SWOT Analysis

9.13.6    Key Developments

9.14     Bexen Medical

9.14.1    Key Facts

9.14.2    Business Description

9.14.3    Products and Services

9.14.4    Financial Overview

9.14.5    SWOT Analysis

9.14.6    Key Developments

10. Appendix

10.1     About The Insight Partners

10.2     Glossary of Terms

List of Tables

Table 1.   Czech Republic Enteral Nutrition Market Segmentation

Table 2.   Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

Table 3.   Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type

Table 4.   Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Country

Table 5.   Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type

Table 6.   Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type

Table 7.   Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories

Table 8.   Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric

Table 9.   Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric

Table 10. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type

Table 11. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End user

Table 12. Glossary of Terms, Czech Republic Enteral Nutrition Market

List of Figures

Figure 1.          Czech Republic Enteral Nutrition Market Segmentation, by Country

Figure 2.          PEST Analysis

Figure 3.          Impact Analysis of Drivers and Restraints

Figure 4.          Czech Republic Enteral Nutrition Market Revenue (US$ Million), 2021–2031

Figure 5.          Czech Republic Enteral Nutrition Market Share (%) – by Product Type, 2023 and 2031

Figure 6.          Nasogastric: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7.          Standard: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.          Disease Specific: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9.          Nasoenteral: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.           Sipping: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11.           Others: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.           Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)

1. Nestle SA
2.  Danone SA
3. Abbott Laboratories
4. Royal FrieslandCampina NV
5. Fresenius SE & Co KGaA
6. B Braun SE
7. Reckitt Benckiser Group Plc
8. Kate Farms Inc
9. Dr Schar AG
10. Fonterra Co-Operative Group Ltd
11. Perrigo Co Plc
12. Arla Foods amba
13. Charing Cross Scientific AS
14.  Bexen Medical

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Czech Republic enteral nutrition market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Czech Republic enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.